• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估MDA-MB-468细胞培养基分析在预测三阴性乳腺癌患者血清代谢谱中的作用。

Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles.

作者信息

Wojtowicz Wojciech, Wróbel Anna, Pyziak Karolina, Tarkowski Radosław, Balcerzak Alicja, Bębenek Marek, Młynarz Piotr

机构信息

Department of Biochemistry, Biotechnology and Molecular Biology, Bioanalytical Laboratory, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland.

Ryvu Therapeutics S.A., Bobrzynskiego 14; 30-348 Krakow, Poland.

出版信息

Metabolites. 2020 Apr 27;10(5):173. doi: 10.3390/metabo10050173.

DOI:10.3390/metabo10050173
PMID:32349447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281562/
Abstract

Triple-negative breast cancer (TNBC) is characterized by limited survival, poor prognosis, and high recurrence. Understanding the metabolic adaptations of TNBC could help reveal improved treatment regiments. Here we performed a comprehensive H NMR metabolic characterization of the MDA-MB-468 cell line, a commonly used model of TNBC, followed by an analysis of serum samples obtained from TNBC patients and healthy controls. MDA-MB-468 cells were cultured, and changes in the metabolic composition of the medium were monitored for 72 h. Based on time courses, metabolites were categorized as being consumed, being produced, or showing a mixed behavior. When comparing TNBC and control samples (HC), and by using multivariate and univariate analyses, we identified nine metabolites with differing profiles). The serum of TNBC patients was characterized by higher levels of glucose, glutamine, citrate, and acetoacetate and by lower levels of lactate, alanine, tyrosine, glutamate, and acetone. A comparative analysis between MDA-MB-468 cell culture media and TNBC patients' serum identified a potential systemic response to the carcinogenesis-associated processes, highlighting that MDA-MB-468 cells footprint does not reflect metabolic changes observed in studied TNBC serum fingerprint.

摘要

三阴性乳腺癌(TNBC)的特征是生存期有限、预后不良和高复发率。了解TNBC的代谢适应性有助于揭示改进的治疗方案。在此,我们对MDA-MB-468细胞系(一种常用的TNBC模型)进行了全面的核磁共振氢谱代谢特征分析,随后分析了TNBC患者和健康对照者的血清样本。培养MDA-MB-468细胞,并监测培养基代谢成分72小时的变化。根据时间进程,将代谢物分为消耗型、产生型或表现出混合行为型。在比较TNBC和对照样本(HC)时,通过多变量和单变量分析,我们鉴定出九种具有不同谱型的代谢物。TNBC患者血清的特征是葡萄糖、谷氨酰胺、柠檬酸盐和乙酰乙酸水平较高,而乳酸、丙氨酸、酪氨酸、谷氨酸和丙酮水平较低。MDA-MB-468细胞培养基与TNBC患者血清之间的比较分析确定了对致癌相关过程的潜在全身反应,突出表明MDA-MB-468细胞特征并不反映在研究的TNBC血清指纹中观察到的代谢变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/88474c9ef115/metabolites-10-00173-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/a6707c995892/metabolites-10-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/7eef3fa9677b/metabolites-10-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/6c3c7ef8c037/metabolites-10-00173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/c1fc32a27a86/metabolites-10-00173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/f58a224b31f9/metabolites-10-00173-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/88474c9ef115/metabolites-10-00173-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/a6707c995892/metabolites-10-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/7eef3fa9677b/metabolites-10-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/6c3c7ef8c037/metabolites-10-00173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/c1fc32a27a86/metabolites-10-00173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/f58a224b31f9/metabolites-10-00173-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4821/7281562/88474c9ef115/metabolites-10-00173-g006.jpg

相似文献

1
Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles.评估MDA-MB-468细胞培养基分析在预测三阴性乳腺癌患者血清代谢谱中的作用。
Metabolites. 2020 Apr 27;10(5):173. doi: 10.3390/metabo10050173.
2
Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.三阴性乳腺癌对叶酸限制的代谢反应。
Nutrients. 2021 May 13;13(5):1637. doi: 10.3390/nu13051637.
3
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.三阴性乳腺癌细胞的代谢谱揭示了代谢弱点。
Cancer Metab. 2017 Aug 22;5:6. doi: 10.1186/s40170-017-0168-x. eCollection 2017.
4
Metabolic and lipidomic characterization of radioresistant MDA-MB-231 human breast cancer cells to investigate potential therapeutic targets.探讨潜在治疗靶点的耐辐射 MDA-MB-231 人乳腺癌细胞的代谢和脂质组学特征。
J Pharm Biomed Anal. 2022 Jan 20;208:114449. doi: 10.1016/j.jpba.2021.114449. Epub 2021 Oct 29.
5
Metabolomics Profiling Reveals the Role of PEDF in Triple-Negative Breast Cancer Cell MDA-MB-231 under Glycaemic Loading.代谢组学分析揭示了色素上皮衍生因子(PEDF)在血糖负荷下三阴性乳腺癌细胞MDA-MB-231中的作用。
Pharmaceutics. 2023 Feb 6;15(2):543. doi: 10.3390/pharmaceutics15020543.
6
Endocan as a prognostic biomarker of triple-negative breast cancer.内皮抑素作为三阴性乳腺癌的预后生物标志物。
Breast Cancer Res Treat. 2017 Jan;161(2):269-278. doi: 10.1007/s10549-016-4057-8. Epub 2016 Nov 25.
7
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.新型含氮查尔酮类似物的设计、合成与三阴性乳腺癌的抑制活性评价。
Eur J Med Chem. 2020 Feb 1;187:111954. doi: 10.1016/j.ejmech.2019.111954. Epub 2019 Dec 7.
8
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics.通过核磁共振代谢组学揭示MDA-MB-231三阴性乳腺癌细胞中顺铂耐药的代谢特征。
Cancer Cell Int. 2023 Dec 6;23(1):310. doi: 10.1186/s12935-023-03124-0.
9
MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.MELK作为控制三阴性乳腺癌MDA-MB-231细胞增殖的潜在靶点。
Oncol Lett. 2018 Jun;15(6):9934-9940. doi: 10.3892/ol.2018.8543. Epub 2018 Apr 20.
10
KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.驱动蛋白家族成员C1(KIFC1):在接受阿霉素联合阿贝西利治疗的Rb阳性三阴性乳腺癌患者中一种可靠的预后生物标志物
Cancer Diagn Progn. 2022 Sep 3;2(5):525-532. doi: 10.21873/cdp.10137. eCollection 2022 Sep-Oct.

引用本文的文献

1
Metabolomics as a tool for understanding and treating triple-negative breast cancer.代谢组学作为理解和治疗三阴性乳腺癌的一种工具。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 2. doi: 10.1007/s00210-025-04234-4.
2
Exploring the complex relationship between metabolomics and breast cancer early detection (Review).探索代谢组学与乳腺癌早期检测之间的复杂关系(综述)。
Mol Clin Oncol. 2025 Feb 20;22(4):35. doi: 10.3892/mco.2025.2830. eCollection 2025 Apr.
3
Microfluidics engineering towards personalized oncology-a review.面向个性化肿瘤学的微流控工程——综述

本文引用的文献

1
Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.体外检测人肾癌的透明细胞肾细胞癌代谢特征分析
J Proteome Res. 2018 Nov 2;17(11):3877-3888. doi: 10.1021/acs.jproteome.8b00538. Epub 2018 Oct 12.
2
Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.单平台“多组学”分析:整合蛋白质组学-代谢组学分析的统一质谱和计算工作流程。
Mol Omics. 2018 Oct 8;14(5):307-319. doi: 10.1039/c8mo00136g.
3
Metabolic fingerprinting in breast cancer stages through H NMR spectroscopy-based metabolomic analysis of plasma.
In Vitro Model. 2023 Jul 13;2(3-4):69-81. doi: 10.1007/s44164-023-00054-z. eCollection 2023 Aug.
4
Microenvironmental G protein-coupled estrogen receptor-mediated glutamine metabolic coupling between cancer-associated fibroblasts and triple-negative breast cancer cells governs tumour progression.微环境中G蛋白偶联雌激素受体介导的癌症相关成纤维细胞与三阴性乳腺癌细胞之间的谷氨酰胺代谢偶联调控肿瘤进展。
Clin Transl Med. 2024 Dec;14(12):e70131. doi: 10.1002/ctm2.70131.
5
Metabolomics and triple-negative breast cancer: A systematic review.代谢组学与三阴性乳腺癌:一项系统综述。
Heliyon. 2023 Dec 13;10(1):e23628. doi: 10.1016/j.heliyon.2023.e23628. eCollection 2024 Jan 15.
6
Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment.双重靶向阿魏酸载药纳米脂质载体用于癌症治疗
Int J Nanomedicine. 2023 Nov 23;18:6979-6997. doi: 10.2147/IJN.S429565. eCollection 2023.
7
Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy.2型糖尿病患者三阴性乳腺癌的最新进展:从危险因素到诊断、生物标志物及治疗
Diagnostics (Basel). 2023 Jul 17;13(14):2390. doi: 10.3390/diagnostics13142390.
8
NMR-Based Metabolomics to Evaluate Individual Response to Treatments.基于核磁共振的代谢组学用于评估个体对治疗的反应。
Handb Exp Pharmacol. 2023;277:209-245. doi: 10.1007/164_2022_618.
9
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.基于 NMR 的代谢组学精准肿瘤学:乳腺癌研究综述。
Int J Mol Sci. 2021 Apr 28;22(9):4687. doi: 10.3390/ijms22094687.
基于血浆中~(1)H NMR 代谢组学分析的乳腺癌各阶段代谢指纹图谱
J Pharm Biomed Anal. 2018 Oct 25;160:38-45. doi: 10.1016/j.jpba.2018.07.024. Epub 2018 Jul 18.
4
Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation.β-羟基丁酸酯(3-OHB)可影响乳腺癌细胞的能量表型,但不影响其增殖以及对化疗或放疗的反应。
Cancer Metab. 2018 Jun 11;6:8. doi: 10.1186/s40170-018-0180-9. eCollection 2018.
5
Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer.二甲双胍作用于三阴性乳腺癌的糖代谢。
J Oncol Transl Res. 2018;4(1). doi: 10.4172/2476-2261.1000129. Epub 2018 Mar 21.
6
Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells.支原体感染和缺氧会导致 VM-M3 癌细胞中琥珀酸的积累和释放。
Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):975-983. doi: 10.1016/j.bbabio.2018.03.012. Epub 2018 Mar 23.
7
Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.非裔美国人三阴性和腔面A型乳腺癌亚型的代谢谱确定了关键的代谢差异。
Oncotarget. 2018 Feb 7;9(14):11677-11690. doi: 10.18632/oncotarget.24433. eCollection 2018 Feb 20.
8
Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.乳腺癌的多平台血浆代谢和脂质指纹图谱:哥伦比亚西班牙裔女性的一项对照病例试点研究。
PLoS One. 2018 Feb 13;13(2):e0190958. doi: 10.1371/journal.pone.0190958. eCollection 2018.
9
HMDB 4.0: the human metabolome database for 2018.HMDB 4.0:2018 年人类代谢组数据库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617. doi: 10.1093/nar/gkx1089.
10
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.谷氨酰胺酶对于谷氨酰胺代谢途径失调的三阴性乳腺癌细胞的生长至关重要,其抑制作用与mTOR抑制协同发挥作用。
PLoS One. 2017 Sep 26;12(9):e0185092. doi: 10.1371/journal.pone.0185092. eCollection 2017.